Skip to main content

Nontuberculous Mycobacteria

  • Chapter
Community-Acquired Pneumonia
  • 1411 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahn, C. H., Lowell, J. R., Ahn, S. I., & Hurst, G. A. (1983). Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am. Rev. Respir. Dis., 128, 1048–1050.

    PubMed  CAS  Google Scholar 

  • Banks, J., Hunter, A. M., Campbell, I. A., Jenkins, P. A., & Smith, A. P. (1983). Pulmonary infection with Mycobacterium kansasiiin Wales, 1970–9: review of treatment and response. Thorax, 38, 271–274.

    PubMed  CAS  Google Scholar 

  • Banks, J. Hunter, A. M., Campbell, I. A., Jenkins, P. A., & Smith, A. P. (1984). Pulmonary infection with Mycobacterium xenopi: review of treatment and response. Thorax, 39, 376–382.

    Article  PubMed  CAS  Google Scholar 

  • Banks, J., Jenkins, P. A., & Smith, A. P. (1985). Pulmonary infection with Mycobacterium malmoense—a review of treatment and response. Tubercle, 66, 197–203.

    Article  PubMed  CAS  Google Scholar 

  • Biehle, J., & Cavalieri, S. J. (1992). In vitro susceptibility of Mycobacterium kansasii to clarithromycin. Antimicrob. Agents Chemother, 36, 2039–2041.

    PubMed  CAS  Google Scholar 

  • Buhler, V. B., & Pollak, A. (1953). Human infection with atypical acid-fast organisms: report of two cases with pathologic findings. Am. J. Clin. Pathol, 23, 363–374.

    PubMed  CAS  Google Scholar 

  • Chaisson, R. E., Benson, C. A., Dube, M. P., Heifets, L. B., Korvick, J. A., Elkin, S., Smith, T, Craft, J. C., Sattler, F. R., & AIDS Clinical Trials Group Protocol 157 Study Team (1994). Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. Ann. Intern. Med., 121, 905–911.

    PubMed  CAS  Google Scholar 

  • Chaisson, R. E., Keiser, P., Pierce, M., Fessel, W. J., Ruskin, J., Lahart, C., Benson, C. A., Meek, K., Siepman, N., & Craft, J. C. (1997). Clarithromycin and ethambutol with or with-out clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. AIDS, II, 311–317.

    Google Scholar 

  • Chatte, G., Panteix, G., Perrin-Fayolle, M., & Pacheco, Y. (1995). Aerosolized interferon gamma for ycobacterium avium-complex lung disease. Am. J. Respir. Crit. Care Med., 152, 1094–1096.

    PubMed  CAS  Google Scholar 

  • Colsky, A. S., Hanly, A., Elgart, G., Kendel, F. A. (1999). Treatment of refractory disseminated Mycobacterium abscessus infection with interferon gamma therapy. Arch. Dermatol., 135, 125–127.

    Article  PubMed  CAS  Google Scholar 

  • Contreras, M. A., Cheung, O. T, Sanders, D. E., & Goldstein, R. S. (1988). Pulmonary infection with nontuberculous mycobacteria. Am. Rev. Respir. Dis., 137, 149–152.

    PubMed  CAS  Google Scholar 

  • Dautzenberg, B., Papillon, F. Lepitre, M., Truffot-Pernod, C., & Chauvin, J. P. (1993). Mycobacterium xenopi infections treated with clarithromycin-containing regimens. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, October 17–20, 1993, New Orleans, LA. Abstract 1125.

    Google Scholar 

  • Falkinham, J. O. III (1996). Epidemiology of infection by non-tuberculous mycobacteria. J. Clin. Microbiol., 9, 177–215.

    Google Scholar 

  • Gordin, F. M., Sullam, P. M., Shafran, S. D., Cohn, D. L., Wynne, B., Paxton, L., Perry K., & Horsburgh, C. R. Jr. (1999). A randomized, placebo-controlled study of rifabutin added to regimen of clarithromycin and ethambutol for the treatment of disseminated Mycobacterium avium complex. Clin. Infect. Dis., 28, 1080–1085.

    PubMed  CAS  Google Scholar 

  • Griffith, D. E., & Wallace, R. J. Jr. (1997). Treatment of pulmonary Mycobacterium avium complex lung disease in non-acquired immunodeficiency syndrome (AIDS) patients in the era of the newer macrolides and rifabutin. Am. J. Med., 102, 22–27.

    CAS  Google Scholar 

  • Griffith, D. E., Girard, W. M., & Wallace, R. J. Jr. (1993). Clinical features of pulmonary disease caused by rapidly growing mycobacteria. Am. Rev. Respir. Dis., 147, 1271–1278.

    PubMed  CAS  Google Scholar 

  • Guthertz, L. S., Damsker, B., Bottone, E. J., Ford, E. G., Midura, T. F., Janda, J. M., (1989). Mycobacterium avium and Mycohacterium intracellulare infections in patients with and without AIDS, J. Infect. Dis., 160, 1037–1041.

    PubMed  CAS  Google Scholar 

  • Henriques, B., Hoffner, S. E., Petrini, B., Juhlin, I., Wáhlén, P., & Källenius, G. (1994). Infection with Mycobacterium malmoense in Sweden: Report of 221 cases. Clin. Infect. Dis., 18, 596–600.

    PubMed  CAS  Google Scholar 

  • Holland, S. M., Eisenstein E. M., Kuhns, D. B., Turner, M. L., Fleisher T. A., Strober W., & Gallin, J. I. (1994). Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N. Engl. J. Med., 330, 1348–1355.

    Article  PubMed  CAS  Google Scholar 

  • Huang, J. H., Kao, P. N., Adi, V, & Ruoss, S. J. (1999). Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease. Chest, 115, 1033–1040.

    PubMed  CAS  Google Scholar 

  • Inderlied, C. B., Kember, C. A., Bermudez, L. E. M. (1993). The Mycobacterium avium complex. Clin. Microbiol. Rev., 6, 266–310.

    PubMed  CAS  Google Scholar 

  • Jenkins, P. A., & Tsukamura, M. (1979). Infections with Mycobacterium malmoense in England and Wales. Tubercle, 60, 71–76.

    Article  PubMed  CAS  Google Scholar 

  • Jenkins, P. A., Banks, J., Campbell, I. A., & Smith, A. P. (1994). Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax, 49, 442–445.

    Google Scholar 

  • O’Brien, R. J., Geiter, L. J., & Snider, D. E. Jr. (1987). The epidemiology of nontuberculous mycobacterial diseases in the United States. Am. Rev. Respir. Dis., 135, 1007–1014.

    Google Scholar 

  • Pang, S. C. (1991). Mycobacterium kansasii infections in Western Australia (1962–1987). Respir. Med., 85, 213–218.

    PubMed  CAS  Google Scholar 

  • Parenti, D. M., Williams, P. L., Hafner, R., Jacobs, M. R., Hojczyk, P., Hooton, T. M., Barber, T. W., Simpson, G., van der Horst, C., Currier, J., Powderly, W. G., Limjoco, M., Ellner, J. J., & the AIDS Clinical Trials Group Protocol 135 Study Team (1998). A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS, 12, 2439–2446.

    Article  PubMed  CAS  Google Scholar 

  • Parrot, R. G., & Grosset, J. H. (1988). Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection. Tubercle, 69, 47–55.

    Article  PubMed  CAS  Google Scholar 

  • Pezzia, W., Raleigh, J. W., Bailey, M. C., Toth, E. A., & Silverblatt, J. (1981). Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. Rev. Infect. Dis., 3, 1035–1039.

    PubMed  CAS  Google Scholar 

  • Schraufnagel, D. E., Leech, J. A., Schraufnagel, M. N., & Pollak, B. (1984). Short-course chemotherapy for Mycobacterium kansasii. Can. Med. Assoc. J., 130, 34–38.

    PubMed  CAS  Google Scholar 

  • Schröder, K. H., & Juhlin, I. (1977). Mycobacterium malmoense sp. nov. Int. J. Syst. Bact., 27, 241–246.

    Google Scholar 

  • Schwabacher, H. (1959). A strain of mycobacterium from skin lesions of a cold blooded animal Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man. J. Hyg. (London), 57, 57–67.

    CAS  Google Scholar 

  • Shafran, S. D., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, M. J., Rachlis, A. R., Lalonde, R. G., Fanning, M. M., Tsourkas, C. M., for the Canadian HIV Trials Network Protocol 010 Study Group (1996). A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS; rifabutin, ethambutol and clarithromycin versus rifampin, ethambutol, clofazimine and ciprofloxacin. N. Engl. J. Med., 345, 377–383.

    Google Scholar 

  • Shafran, S. D., Talbot, J. A., Chomyc, C., Davison, E., Singer, J., Phillips, P., Salit, I. E., Walmsley, S. L., Fong, I. W., Gill, M. J., Rachlis, A. R., Lalonde, R. G., & Canadian HIV Trials Network Protocol 010 Study Group (1998). Does in vitro susceptibility to rifabutin and ethambutol predict response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol and clarithromycin? Clin. Infect. Dis., 27, 1401–1405.

    PubMed  CAS  Google Scholar 

  • Simor, A. E., Salit, I. E., & Vellend, H. (1984). The role of Mycobacterium xenopi in human disease. Am. Rev. Respir. Dis., 129, 435–438.

    PubMed  CAS  Google Scholar 

  • Smith, M. J., & Citron, K. M. (1983). Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax, 38, 373–377.

    PubMed  CAS  Google Scholar 

  • Thorel, M. F., Krichevsky, M., & Frebault-Levy, V. V. (1990). Numerical taxonomy of mycobactin-dependent mycobacleria, amended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium nov., Mycobacterium avium subsp. paratuberculosis nov., and Mycobacterium avium subsp. silvaticum nov. Int. J. Syst. Bacteriol., 40, 254–260.

    Article  PubMed  CAS  Google Scholar 

  • Timpe, A., & Runyon, E. H. (1954). The relationship of “atypical” cid-fast bacteria to human disease. J. Lab. Clin. Med., 44, 202–209.

    PubMed  CAS  Google Scholar 

  • Wallace, R. J. Jr., (1994). Mycobacterium avium complex lung disease and women. Now an equal opportunity disease. Chest, 105, 6–7.

    PubMed  Google Scholar 

  • Wallace, R. J. Jr., Swenson, J. M, Silcox, V. A., Good, R. C., Tschen, J. A., & Stone, M. S. (1983). Spectrum of disease due to rapidly growing mycobacteria. Rev. Infect. Dis., 5, 657–679.

    PubMed  Google Scholar 

  • Wallace, R. J. Jr., Swenson, J. M., Silcox, V. A., & Bullen, M. G. (1985). Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J. Infect. Dis., 152, 500–514.

    PubMed  Google Scholar 

  • Wallace, R. J. Jr., Dunbar, D., Brown, B. A., Onyi, G., Dunlap, R., Ahn, C. H., Murphy, D. T. (1994). Rifampin-resistant Mycobacterium kansasii. Clin. Infect. Dis., 18. 736–743.

    PubMed  CAS  Google Scholar 

  • Wallace, R. J. Jr., Glasroth, J., Griffith, D. E., Olivier, K. N., Cook, J. L., & Gordin, F. (1997). Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med., 156, S1–S25.

    Google Scholar 

  • Wayne, L. G., & Sramek, H. A. (1992). Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin. Microbiol. Rev., 5, 1–25.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Shafran, S.D. (2002). Nontuberculous Mycobacteria. In: Marrie, T.J. (eds) Community-Acquired Pneumonia. Springer, Boston, MA. https://doi.org/10.1007/0-306-46834-4_50

Download citation

  • DOI: https://doi.org/10.1007/0-306-46834-4_50

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46432-4

  • Online ISBN: 978-0-306-46834-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics